COM:FARON
Faron Pharmaceuticals Ltd.
- Stock
Last Close
142.50
22/11 14:00
Market Cap
1.36M
Beta: -
Volume Today
20.05K
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '13 | Dec '14 | Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
average inventory | 822.50K - | 899K 9.30% | 674K 25.03% | 1.05M 55.79% | 725.50K 30.90% | |||||||
average payables | 67K - | 27.50K 58.96% | 223K 710.91% | 1.16M 417.94% | 2.54M 119.48% | 3.37M 32.74% | 3.25M 3.40% | 3.79M 16.52% | 3.42M 9.74% | 4.12M 20.56% | 7.49M 81.79% | |
average receivables | 1.04M - | 1.04M 0% | ||||||||||
book value per share | -0.04 - | -0.05 25.18% | 0.48 1,040.91% | 0.45 6.16% | 0.17 62.53% | 0.01 92.94% | 0.04 213.67% | -0.04 207.48% | 0.06 242.22% | -0.23 493.28% | ||
capex per share | -0.00 - | -0.01 106.85% | -0.00 29.14% | -0.00 17.13% | -0.00 8.41% | -0.01 173.01% | -0.00 75.63% | -0.00 32.89% | -0.01 200.82% | -0.01 18.78% | ||
capex to depreciation | -1.30 - | -2.52 93.06% | -0.58 76.89% | -0.55 5.83% | -1.29 135.47% | -2.95 128.78% | -0.42 85.76% | -0.50 19.42% | -1.54 207.71% | -1.28 16.88% | -0.36 72.30% | |
capex to operating cash flow | 0.10 - | 0.39 308.38% | 0.01 96.14% | 0.01 27.30% | 0.01 50.97% | 0.01 169.31% | 0.01 39.62% | 0.01 6.39% | 0.02 162.60% | 0.02 21.51% | 0.01 69.14% | |
capex to revenue | -0.36 - | -0.17 54.34% | -0.21 23.46% | -0.08 61.22% | -15.53 - | |||||||
cash per share | 0.01 - | 0.48 4,473.55% | 0.48 0.05% | 0.33 30.26% | 0.13 60.38% | 0.17 24.78% | 0.09 45.54% | 0.14 50.34% | 0.14 2.00% | |||
days of inventory on hand | 4.01K - | 637.84 84.10% | 9.48K 1,385.55% | |||||||||
days payables outstanding | 164.25 - | 9.13 94.44% | 6.37K 69,660% | |||||||||
days sales outstanding | 1.46K - | |||||||||||
debt to assets | 0.91 - | 0.78 14.06% | 0.14 81.63% | 0.12 14.31% | 0.16 32.51% | 0.27 63.50% | 0.28 3.75% | 0.39 39.44% | 0.27 30.19% | 1.18 337.52% | 1.28 8.97% | |
debt to equity | -2.14 - | -1.42 33.56% | 0.19 113.37% | 0.20 2.66% | 0.51 161.83% | 5.78 1,029.60% | 1.75 69.66% | -1.74 199.51% | 1.22 169.69% | -1.16 195.12% | -0.86 25.21% | |
dividend yield | ||||||||||||
earnings yield | -0.02 - | -0.02 15.36% | -0.08 390.18% | -0.12 54.26% | -0.08 35.51% | -1.06 1,215.32% | -0.10 90.53% | -0.13 28.47% | -0.13 1.85% | -0.17 33.30% | ||
enterprise value | 79.42M - | 84.15M 5.95% | 67.60M 19.67% | 65.17M 3.59% | 254.96M 291.23% | 17.05M 93.31% | 128.17M 651.65% | 130.81M 2.06% | 158.41M 21.10% | 178.19M 12.49% | 6.24M 96.50% | |
enterprise value over ebitda | -55.93 - | -69.20 23.73% | -11.41 83.51% | -7.22 36.73% | -12.19 68.89% | -0.87 92.84% | -10.02 1,047.54% | -8.04 19.75% | -7.68 4.56% | -6.59 14.12% | ||
ev to operating cash flow | -103.41 - | -216.32 109.19% | -9.46 95.63% | -7.71 18.49% | -13.88 80.07% | -0.83 94.02% | -11.12 1,238.85% | -7.48 32.72% | -7.13 4.73% | -7.75 8.70% | -0.26 96.62% | |
ev to sales | 397.09 - | 92.88 76.61% | 129.99 39.96% | 56.52 56.52% | 897.44 - | |||||||
free cash flow per share | -0.04 - | -0.02 35.79% | -0.31 1,243.15% | -0.36 13.54% | -0.66 85.79% | -0.68 2.28% | -0.27 59.87% | -0.39 41.88% | -0.45 16.05% | -0.46 3.02% | ||
free cash flow yield | -0.01 - | -0.01 39.92% | -0.09 1,351.25% | -0.11 20.99% | -0.07 38.51% | -1.10 1,455.33% | -0.09 91.99% | -0.13 52.42% | -0.14 4.87% | -0.14 3.09% | ||
graham net net | -0.11 - | -0.12 4.74% | 0.40 436.98% | 0.24 39.93% | -0.03 112.37% | -0.12 287.78% | -0.04 68.95% | -0.13 271.19% | -0.07 49.67% | -0.31 361.95% | ||
graham number | 0.25 - | 0.26 6.41% | 1.71 553.34% | 1.99 16.55% | 1.70 14.55% | 0.42 75.30% | 0.51 22.02% | 0.58 13.37% | 0.74 26.61% | 1.74 136.08% | ||
income quality | 0.51 - | 0.29 44.00% | 1.16 307.83% | 0.91 21.81% | 0.87 4.12% | 1.02 17.21% | 0.87 14.91% | 1.03 18.68% | 1.05 1.57% | 0.80 23.66% | 0.77 3.87% | |
intangibles to total assets | 0.49 - | 0.55 11.93% | 0.07 87.65% | 0.05 20.09% | 0.02 59.55% | 0.07 200.53% | 0.05 21.02% | 0.07 30.32% | 0.07 0.99% | 0.10 50.13% | 0.11 3.98% | |
interest coverage | -38.75 - | -14.98 61.35% | -153.55 925.35% | -354.32 130.75% | -275.45 22.26% | -165.20 40.03% | -58.49 64.60% | -42.81 26.80% | -89.82 109.80% | -19.59 78.19% | ||
interest debt per share | 0.09 - | 0.08 14.14% | 0.09 22.11% | 0.09 4.24% | 0.09 0.02% | 0.07 18.30% | 0.07 2.80% | 0.08 11.04% | 0.07 5.69% | 0.29 287.86% | ||
inventory turnover | 0.09 - | 0.57 528.90% | 0.04 93.27% | |||||||||
invested capital | -2.14 - | -1.42 33.56% | 0.19 113.37% | 0.20 2.66% | 0.51 161.83% | 5.78 1,029.60% | 1.75 69.66% | -1.74 199.51% | 1.22 169.69% | -1.16 195.12% | -0.86 25.21% | |
market cap | 77.39M - | 82.70M 6.87% | 76.54M 7.45% | 74.52M 2.64% | 261.84M 251.37% | 18.99M 92.75% | 132.40M 597.36% | 131.69M 0.54% | 161.71M 22.80% | 171.91M 6.31% | ||
net current asset value | -2.04M - | -2.37M 16.16% | 10.15M 527.82% | 9.93M 2.16% | 3.09M 68.92% | -808K 126.18% | 605K 174.88% | -2.85M 570.25% | 1.76M 161.83% | -13.02M 840.02% | -16.51M 26.86% | |
net debt to ebitda | -1.43 - | -1.19 16.77% | 1.51 226.66% | 1.04 31.35% | 0.33 68.22% | 0.10 69.90% | 0.33 234.30% | 0.05 83.61% | 0.16 195.08% | -0.23 245.00% | ||
net income per share | -0.07 - | -0.06 9.55% | -0.27 353.67% | -0.39 44.76% | -0.76 94.84% | -0.65 13.50% | -0.31 52.53% | -0.37 19.58% | -0.42 12.71% | -0.59 41.71% | ||
operating cash flow per share | -0.03 - | -0.02 49.35% | -0.31 1,737.02% | -0.35 13.99% | -0.66 86.81% | -0.67 1.37% | -0.27 59.64% | -0.38 41.96% | -0.44 14.55% | -0.45 3.49% | ||
payables turnover | 2.22 - | 40 1,700% | 0.06 99.86% | |||||||||
receivables turnover | 0.25 - | |||||||||||
research and ddevelopement to revenue | 10.15 - | 1.65 83.74% | 7.64 362.48% | 8.32 8.94% | 843.84 - | |||||||
return on tangible assets | -1.32 - | -1.39 5.48% | -0.45 67.80% | -0.57 26.92% | -1.45 154.48% | -2.69 85.75% | -1.37 49.00% | -2.17 58.54% | -1.73 20.56% | -2.97 72.05% | ||
revenue per share | 0.01 - | 0.04 353% | 0.02 42.60% | 0.05 113.71% | 0.00 - | |||||||
roe | 1.59 - | 1.15 27.75% | -0.55 148.22% | -0.85 54.27% | -4.44 419.94% | -54.43 1,125.92% | -8.24 84.87% | 9.16 211.26% | -7.26 179.25% | 2.62 136.03% | ||
roic | -1.35 - | -2.45 82.02% | -0.44 81.99% | -0.69 55.46% | -2.88 319.82% | -7.99 177.36% | -2.72 66.02% | -9.52 250.42% | -3.17 66.70% | -13.59 328.93% | ||
sales general and administrative to revenue | 0.99 - | 0.39 61.29% | 5.89 1,428.14% | 1.87 68.16% | 197.37 - | |||||||
shareholders equity per share | -0.04 - | -0.05 25.18% | 0.48 1,040.91% | 0.45 6.16% | 0.17 62.53% | 0.01 92.94% | 0.04 213.67% | -0.04 207.48% | 0.06 242.22% | -0.23 493.28% | ||
stock based compensation to revenue | 0.83 - | 0.42 49.66% | -9.26 - | |||||||||
tangible asset value | -2.04M - | -2.37M 16.16% | 10.18M 529.05% | 9.95M 2.23% | 4.42M 55.60% | -156K 103.53% | 1.08M 792.95% | -2.41M 323.31% | 2.02M 183.64% | -12.63M 725.56% | -16.25M 28.65% | |
tangible book value per share | -0.09 - | -0.10 16.16% | 0.44 529.05% | 0.41 5.77% | 0.16 61.82% | -0.01 103.20% | 0.03 598.17% | -0.05 308.99% | 0.04 175.37% | -0.25 725.56% | ||
working capital | -597K - | -681K 14.07% | 11.59M 1,802.50% | 11.96M 3.17% | 5.17M 56.75% | 1.08M 79.13% | 3.13M 189.72% | 868K 72.26% | 4.84M 458.18% | -741K 115.29% | -6.14M 729.15% |
All numbers in GBP (except ratios and percentages)